• 제목, 요약, 키워드: Iran

검색결과 1,258건 처리시간 0.052초

Challenges to Promoting Population-Based Cancer Registration in Iran: a Workshop Report

  • Hadji, Maryam;Nahvijou, Azin;Seddighi, Zahra;Beiki, Omid;Mohagheghi, Mohammad Ali;Mosavi-Jarrahi, Alireza;Marnani, Ahmad Barati;Zendehdel, Kazem
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.14 no.10
    • /
    • pp.6189-6193
    • /
    • 2013
  • In December 2011, the Cancer Research Centre of the Cancer Institute of Iran sponsored a 3-day workshop on "Cancer Registration Principle and Challenges in Iran", which convened cancer registry experts. The objectives of the workshop were: to introduce standard cancer registration, to review the policy and procedure of cancer registration in Iran, and to review the best practices in the cancer registries in Iran. Challenges to cancer registration were discussed and recommendations were developed. The workshop was evaluated by participants for better organization of subsequent workshops. The objective of publication of this report is that based on Cancer in 5 Continents, many low- or middle-income countries do not meet the criteria for a standard population-based cancer registry (PBCR); on the other hand cancer is the most important cause of mortality and the essential part of any cancer control program is the cancer registry. Therefore this report focuses on problems and challenges of PBCR and provides recommendations which might help other developing countries to decrease their PBCR defects.

Spiritual Care for Cancer Patients in Iran

  • Memaryan, Nadereh;Jolfaei, Atefeh Ghanbari;Ghaempanah, Zeinab;Shirvani, Armin;Vand, Hoda Doos Ali;Ghahari, Shahrbanoo;Bolhari, Jafar
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.17 no.9
    • /
    • pp.4289-4294
    • /
    • 2016
  • Background: Studies have shown that a return to spirituality is a major coping response in cancer patients so that therapists can adopt a holistic approach by addressing spirituality in their patient care. The present study was conducted to develop a guideline in the spiritual field for healthcare providers who serve cancer patients in Iran. Materials and Methods: Relevant statements were extracted from scientific documents that through study questions were reviewed and modified by a consensus panel. Results: The statements were arranged in six areas, including spiritual needs assessment, spiritual care candidates, the main components of spiritual care, spiritual care providers, the settings of spiritual care and the resources and facilities for spiritual care. Conclusions: In addition to the development and preparation of these guidelines, health policy-makers should also seek to motivate and train health service providers to offer these services and facilitate their provision and help with widespread implementation.

Measuring and Decomposing Socioeconomic Inequality in Catastrophic Healthcare Expenditures in Iran

  • Rezaei, Satar;Hajizadeh, Mohammad
    • Journal of Preventive Medicine and Public Health
    • /
    • v.52 no.4
    • /
    • pp.214-223
    • /
    • 2019
  • Objectives: Equity in financial protection against healthcare expenditures is one the primary functions of health systems worldwide. This study aimed to quantify socioeconomic inequality in facing catastrophic healthcare expenditures (CHE) and to identify the main factors contributing to socioeconomic inequality in CHE in Iran. Methods: A total of 37 860 households were drawn from the Households Income and Expenditure Survey, conducted by the Statistical Center of Iran in 2017. The prevalence of CHE was measured using a cut-off of spending at least 40% of the capacity to pay on healthcare services. The concentration curve and concentration index (C) were used to illustrate and measure the extent of socioeconomic inequality in CHE among Iranian households. The C was decomposed to identify the main factors explaining the observed socioeconomic inequality in CHE in Iran. Results: The prevalence of CHE among Iranian households in 2017 was 5.26% (95% confidence interval [CI], 5.04 to 5.49). The value of C was -0.17 (95% CI, -0.19 to -0.13), suggesting that CHE was mainly concentrated among socioeconomically disadvantaged households in Iran. The decomposition analysis highlighted the household wealth index as explaining 71.7% of the concentration of CHE among the poor in Iran. Conclusions: This study revealed that CHE is disproportionately concentrated among poor households in Iran. Health policies to reduce socioeconomic inequality in facing CHE in Iran should focus on socioeconomically disadvantaged households.

한국자동차기업의 이란진출을 위한 전략제안 (Some Suggestions for Korean Automobile Industry to Branch out into Iran)

  • 김현철
    • 국제지역연구
    • /
    • v.21 no.1
    • /
    • pp.163-179
    • /
    • 2017
  • 미국이 이란에 대한 1차 제재를 제외한 나머지 경제제재를 해제함에 따라 이란은 글로벌 자동차기업들의 해외직접투자 대상으로 급부상했다. 이 연구는 이런 배경에서 한국의 자동차산업이 이란에 진출하는 방법에 대한 전략적 제안을 하고 있다. 이를 위해 이란의 자동차산업과 이란의 특징에 대해 먼저 탐구하였으며, 시장 상황에 대한 정량적 정성적 분석을 하고 있다. 승용차부문에서, 한국의 완성차기업들은 미-이란 관계의 진전을 좀 더 지켜보면서 대신 CKD를 수출하는 것이 바람직할 것으로 보인다. 그러나 이란 정부가 CKD의 수출만으로는 만족하지 못할 것이므로, 부품회사들은 미리 진출시키는 것이 바람직할 것이다. 부품회사들의 경우에는 해외직접투자, 라이센스 방식의 진출, 그리고 합작기업의 형태가 모두 가능하다. 이를 통해 자동차기업들은 부품현지화 비율 규제를 만족시킬 수 있다. 이렇게 투자한 부품회사들은 나중에 조건이 호전되어 완성차기업들이 진출했을 때 현지의 서플라이 체인 구축에 핵심역할을 하게 될 것이다. 또 이란에 구축하게 될 자동차 생산기반은 이란을 넘어서 중동-북아프리카 지역의 수출전략기지화 하는 것도 제안할 수 있다. 수출기지화 한다면 동유럽에 구축된 생산기반과 역할 분담 모델이 필요할 것이다. 이런 전략은 전체적으로 보면 부품우선진출 전략이라고 할 수 있을 것이다. 상용차부문의 경우, 천연가스산업을 이란에 진출하는 전략적 고리로 사용할 것을 제안한다. 이란 정부는 천연자원 개발을 강력하게 희망하고 있다. 따라서 완성차기업들은 CNG버스를 생산하고 에너지기업들은 천연가스를 시굴 생산하는 연계진출 방안이다.

Molecular Variation and Distribution of Anopheles fluviatilis (Diptera: Culicidae) Complex in Iran

  • Naddaf, Saied Reza;Razavi, Mohammad Reza;Bahramali, Golnaz
    • The Korean Journal of Parasitology
    • /
    • v.48 no.3
    • /
    • pp.231-236
    • /
    • 2010
  • Anopheles fluviatilis James (Oiptera: Culicidae) is one of the known malaria vectors in south and southeastern Iran. Earlier ITS2 sequences analysis of specimens from Iran demonstrated only a single genotype that was identical to species Y in India, which is also the same as species T. We identified 2 haplotypes in the An. fluviatilis populations of Iran based on differences in nucleotide sequences of D3 domain of the 28S locus of ribosomal DNA (rDNA). Comparison of sequence data from 44 Iranian specimens with those publicly available in the Genbank database showed that all of the 288-D3 sequences from Kazeroun and Khesht regions in Fars Province were identical to the database entry representing species U in India. In other regions, all the individuals showed heterozygosity at the single nucleotide position, which identifies species U and T. It is argued that the 2 species may co-occur in some regions and hybridize; however, the heterozygosity in the 288-D3 locus was not reflected in ITS2 sequences and this locus for all individuals was identical to species T. This study shows that in a newly diverged species, like members of An. fluviatilis complex, a single molecular marker may not be sufficiently discriminatory to identify all the taxa over a vast geographical area. In addition, other molecular markers may provide more reliable information for species discrimination.

A novel variant of t-PA resistant to plasminogen activator inhibitor-1; expression in CHO cells based on In Silico experiments

  • Davami, Fatemeh;Sardari, Soroush;Majidzadeh-A, Keivan;Hemayatkar, Mahdi;Barkhordari, Farzaneh;Enayati, Somayeh;Adeli, Ahmad;Mahboudi, Fereidoun
    • BMB Reports
    • /
    • v.44 no.1
    • /
    • pp.34-39
    • /
    • 2011
  • Resistance to PAI-1 is a factor which confers clinical benefits in thrombolytic therapy. The only US FDA approved PAI-1 resistant drug is Tenecteplase$^{(R)}$. Deletion variants of t-PA have the advantage of fewer disulfide bonds in addition to higher plasma half lives. A new variant was developed by deletion of the first three domains in t-PA in addition to substitution of KHRR 128-131 amino acids with AAAA in truncated t-PA. The specific activity of this new variant, $570\;IU/{\mu}g$, was found to be similar to those found in full length t-PA (Alteplase$^{(R)}$), $580\;IU/{\mu}g$. A 65% and 85% residual activity after inhibition by rPAI-1 was observed for full length and truncated-mutant form, respectively. This new variant as the first PAI-1 resistant truncated t-PA may offer more advantages in clinical conditions in which high PAI-1 levels makes the thrombolytic system prone to re-occlusion.